Constructing 177Lu-Labeled Lanthanide Nano-Radiopharmaceuticals for Efficient Postoperative Tumor Radionuclide Therapy and Prognosis Monitoring.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the American Chemical Society"
DOI: 10.1021/jacs.5c14832
Abstract: Cancer remains a global health challenge, with current postoperative adjuvant therapies for advanced solid tumors being limited by therapeutic resistance, off-target effects, and insufficient treatment monitoring. Here, we report a rational design of a novel… read more here.
Keywords: prognosis monitoring; labeled lanthanide; tumor; her2 ... See more keywords
In vivo and in vitro evaluation of 177Lu-labeled DOTA-2-deoxy-D-glucose in mice. A novel radiopharmaceutical agent for cells imaging and therapy.
Sign Up to like & getrecommendations! Published in 2019 at "Hellenic journal of nuclear medicine"
DOI: 10.1967/s002449911002
Abstract: OBJECTIVE Incorporation of lutetium-177 (177Lu) into suitable molecules that are implicated in cancer pathology represents a promising approach for the diagnosis and treatment of cancer. The goal of the present study was to develop a… read more here.
Keywords: radiopharmaceutical agent; dota; 177lu labeled; 177lu dota ... See more keywords
Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics13040536
Abstract: The decay of terbium-161 results in the emission of β¯-particles as well as conversion and Auger electrons, which makes terbium-161 interesting for therapeutic purposes. The aim of this study was to use dual-isotope SPECT imaging… read more here.
Keywords: 161tb 177lu; dual isotope; spect imaging; terbium 161 ... See more keywords